Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and inflammatory cytokines in coronary artery bypass graft surgery
IRCT20141009019470N73Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in coronary arteriosclerosis and chronic inflammation, sponsored by Shiraz University of Medical Sciences. Primary endpoint: Change in inflammatory cytokines. Started Apr 2018; status: completed.
02
Drugs
melatonin
03
Conditions
coronary arteriosclerosischronic inflammation
Beyond the preview
Go deeper on IRCT20141009019470N73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N73.